ADVERTISEMENT
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Related topics
PRESS RELEASE: Paid content from PR Newswire
Press release content from PR Newswire. The AP news staff was not involved in its creation.

Endo to Announce Third Quarter 2021 Financial Results

October 5, 2021 GMT
(PRNewsfoto/Endo International plc)
(PRNewsfoto/Endo International plc)
(PRNewsfoto/Endo International plc)

DUBLIN, Oct. 5, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) will announce its third–quarter 2021 financial results on November 4, 2021 and members of its senior management team will host a conference call and webcast on November 5, 2021 at 7:30am ET before the U.S. financial markets open.

The dial-in number to access the call is U.S./Canada (866) 497-0462, International (678) 509-7598, and the passcode is 6052178. Please dial in 10 minutes prior to the scheduled start time.

A replay of the call will be available from November 5, 2021 at 10:30 a.m. ET until 9:30 a.m. ET on November 12, 2021 by dialing U.S./Canada (855) 859-2056 International (404) 537-3406, and entering the passcode 6052178.

A simultaneous webcast of the call can be accessed by https://edge.media-server.com/mmc/p/ioyk5xzt. In addition, a replay of the webcast will be available on the Company website for one year following the event.

ADVERTISEMENT

About Endo International plc

Endo (NASDAQ: ENDP) is a specialty pharmaceutical company committed to helping everyone we serve live their best life through the delivery of quality, life-enhancing therapies. Our decades of proven success come from a global team of passionate employees collaborating to bring the best treatments forward. Together, we boldly transform insights into treatments benefiting those who need them, when they need them. Learn more at www.endo.com or connect with us on LinkedIn.

View original content to download multimedia: https://www.prnewswire.com/news-releases/endo-to-announce-third-quarter-2021-financial-results-301393438.html

SOURCE Endo International plc